Status:
COMPLETED
NIR-Guided Sentinel Lymph-Node Mapping for Esophageal Cancer
Lead Sponsor:
Dana-Farber Cancer Institute
Conditions:
Esophageal Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
This research study is a Phase I clinical trial. Phase I clinical trials test the feasibility and safety of an investigational technique or drug. This study will try to define an appropriate dose of t...
Detailed Description
If you are willing to participate in this study you will be asked to undergo a review of your medical history to confirm that you are eligible. If this review shows that you are eligible you will begi...
Eligibility Criteria
Inclusion
- Suspected or confirmed esophageal cancer
- Deemed an appropriate surgical candidate with consent for esophagectomy and lymphadenectomy or staging lymphadenectomy by their thoracic surgeon
Exclusion
- Patients who choose not to proceed with surgery
- History of allergic reactions attributed to compounds of similar chemical or biologic composition to indocyanine green, including thos patients with a history of iodide or seafood allergy
- Women who are pregnant or breastfeeding
Key Trial Info
Start Date :
June 21 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 7 2015
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01808417
Start Date
June 21 2013
End Date
April 7 2015
Last Update
December 2 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02215
2
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215